scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.IJROBP.2015.09.011 |
P698 | PubMed publication ID | 26700706 |
P50 | author | Sharad Goyal | Q37830941 |
Bruce G Haffty | Q62127887 | ||
Dirk Moore | Q89142945 | ||
Chunxia Chen | Q90653157 | ||
Laurie Kirstein | Q114739951 | ||
Stuti Ahlawat | Q114739955 | ||
P2093 | author name string | Thomas Kearney | |
Atif J. Khan | |||
P2860 | cites work | Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials | Q29031162 |
Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years | Q33723980 | ||
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials | Q34054354 | ||
Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013. | Q34742937 | ||
Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer | Q36166224 | ||
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. | Q36514573 | ||
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial | Q36571627 | ||
Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost | Q36767280 | ||
Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue | Q36807209 | ||
Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast | Q37509647 | ||
Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. | Q37773606 | ||
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial | Q43427825 | ||
Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions | Q43722411 | ||
Five-year results of a prospective case series of accelerated hypofractionated whole breast radiation with concomitant boost to the surgical bed after conserving surgery for early breast cancer | Q44057851 | ||
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer | Q44230659 | ||
Choosing wisely: the American Society for Radiation Oncology's top 5 list. | Q45005764 | ||
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. | Q46425805 | ||
A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction | Q46590180 | ||
Long-term results of hypofractionated radiation therapy for breast cancer | Q48887913 | ||
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). | Q53213927 | ||
Hypofractionation with simultaneous integrated boost for early breast cancer | Q57338044 | ||
Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France | Q73132146 | ||
Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients | Q77947503 | ||
Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation | Q86699248 | ||
Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India | Q95588723 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adaptive radiation therapy | Q180507 |
phase II clinical trial | Q42824440 | ||
P304 | page(s) | 118-125 | |
P577 | publication date | 2016-01-01 | |
P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
P1476 | title | Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial | |
P478 | volume | 94 |
Q38811255 | Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial |
Q57108643 | Hypofractionated radiation treatment in the management of breast cancer |
Q88262647 | Normal tissue damage: its importance, history and challenges for the future |
Q55362979 | Predictors of radiation-induced acute skin toxicity in breast cancer at a single institution: Role of fractionation and treatment volume. |
Q53980225 | Relation between Hypofractionated Radiotherapy, Toxicity and Outcome in Early Breast Cancer. |
Search more.